Stay updated on Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial

Sign up to get notified when there's something new on the Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The clinical-trial record for the NC-6004 and pembrolizumab study in recurrent or metastatic head and neck cancer is displayed, with details on study design, eligibility, participating locations, and measured outcomes.
    Difference
    57%
    Check dated 2026-11-07T13:16:22.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:02:14.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A banner announces the NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T15:34:18.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T15:23:52.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:25:06.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, rendering the study record inaccessible. This indicates a site access/configuration issue rather than an update to the study content.
    Difference
    18%
    Check dated 2026-09-19T20:42:03.000Z thumbnail image

Stay in the know with updates to Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Anti-PD1 in Head & Neck Melanoma Clinical Trial page.